Aradigm Corporation
Aradigm Presents Phase 2 Data on Inhaled Liposomal Ciprofloxacin in Cystic Fibrosis and Non-Cystic Fibrosis Bronchiectasis at 2009 International Conference of the American Thoracic Society
Published in Genetics and Environmental Health Week, June 3rd, 2009
Aradigm Corporation (OTCBB:ARDM) ("Aradigm") announced it is presenting data from its Phase 2a studies of inhaled liposomal ciprofloxacin in cystic fibrosis (CF) and in non-CF bronchiectasis (BE) patients at the 2009 International Conference of the American Thoracic Society in San Diego, California. ABSTRACT NUMBER: 4089 [Poster Board #E20] ABSTRACT TITLE: Inhaled Liposomal Ciprofloxacin Hydrochloride Significantly Reduces Sputum Pseudomonas Aeruginosa Density in CF and Non-CF Bronchiectasis AUTHORS: Diana Bilton MD*, Paul Bruinenberg MD, Babatunde Otulana, MD, Jim Blanchard PhD, Antony DeSoyza MD*, David Serisier MD, Aradigm Corporation, Hayward, CA. * Royal Brompton Hospital, London...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Genetics and Environmental Health Week
More Articles from Genetics and Environmental Health Week
- Allergies Risk Factors
Research reports on allergies risk factors from F. Sánchez-Valverde and colleagues provide new insights - Cancer Genetics
New cancer genetics research from Cancer Research Center outlined - Contact Dermatitis
Research findings from M.R.A. Hussein et al update understanding of contact dermatitis - Dementia
Findings in dementia reported from Medical University of Vienna - Genetics
New genetics study findings recently were reported by M.F. Leber and co-researchers - Hemochromatosis
Research conducted at W.H. Rogowski and co-authors has provided new information about hemochromatosis - More from this issue of Genetics and Environmental Health Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
